Filing Details

Accession Number:
0001209191-13-040749
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-14 18:04:35
Reporting Period:
2013-08-12
Filing Date:
2013-08-14
Accepted Time:
2013-08-14 18:04:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Biotime Inc BTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1536529 C. Andrew Eschenbach Von 163 Sarasota Circle South
Montgomery TX 77356
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2013-08-12 3,000 $3.69 3,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Option to Purchase Common Shares $4.13 2018-06-30 20,000 20,000 Direct
Common Shares Option to Purchase Common Shares $4.60 2017-06-30 20,000 20,000 Direct
Common Shares Option to Purchase Common Shares $4.06 2016-11-27 20,000 20,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-06-30 20,000 20,000 Direct
2017-06-30 20,000 20,000 Direct
2016-11-27 20,000 20,000 Direct
Footnotes
  1. Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2013 based upon continued service on the board of directors.
  2. 5,000 options became exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013.
  3. 5,000 options became exercisable on December 31, 2011; March 31, 2012; June 30, 2012, and September 30, 2012.